Winstock A R, Sheridan J, Lovell S, Farrell M, Strang J
The National Addiction Centre, Institute of Psychiatry/Maudsley Hospital, London, UK.
Eur J Clin Microbiol Infect Dis. 2000 Nov;19(11):823-8. doi: 10.1007/s100960000377.
Since viral hepatitis among intravenous drug users continues to be a major cause of morbidity and mortality, the present study was conducted to survey drug agencies in England and Wales in order to identify the prevalence of hepatitis B and C testing and vaccination being provided. A postal survey of all 539 drug agencies in England and Wales was thus conducted to assess their current treatment provisions and practices. An analysis of the responses provided by the 373 agencies that returned usable data (69.2% response rate) revealed that only one-quarter (26.6%) of the drug agencies conducted routine hepatitis B testing, and 26.9% did not offer it at all. Just over half (55.7%) of the agencies provided hepatitis B vaccination, but only 21.7% did so routinely. Seventy percent provided hepatitis C testing, but only 24% did so routinely. Nevertheless, the majority of respondents, of whom 40.3% were nurses and 25.1% drug workers, believed that clients and their partners should be offered hepatitis B and C screening. The paucity of hepatitis testing and vaccination services being offered to injecting drug users is unacceptable, with users, their partners and children being needlessly exposed to continued risk. The disparity between recommended policy and current practice needs to be urgently addressed.
由于静脉注射吸毒者中的病毒性肝炎仍然是发病和死亡的主要原因，因此开展了本研究，以调查英格兰和威尔士的戒毒机构，以便确定乙肝和丙肝检测及疫苗接种的普及情况。因此，对英格兰和威尔士的所有539家戒毒机构进行了邮政调查，以评估其目前的治疗措施和做法。对373家返回可用数据的机构（回复率为69.2%）提供的回复进行分析后发现，只有四分之一（26.6%）的戒毒机构进行常规乙肝检测，26.9%的机构根本不提供此项检测。略超过一半（55.7%）的机构提供乙肝疫苗接种，但只有21.7%的机构定期提供。70%的机构提供丙肝检测，但只有24%的机构定期进行。然而，大多数受访者（其中40.3%是护士，25.1%是戒毒工作者）认为，应该为服务对象及其伴侣提供乙肝和丙肝筛查。向注射吸毒者提供的肝炎检测和疫苗接种服务匮乏，这是不可接受的，因为吸毒者及其伴侣和子女正不必要地面临持续的风险。建议的政策与当前做法之间的差距需要紧急解决。
